Hydroxyfasudil hydrochloride is a cell-permeable, hydroxylated metabolite of HA 1077 (Fasudil) that displays anti-anginal properties. Acts as an ATP-competitive and a reversible inhibitor of Rock (Rho-kinase) (IC50 = 0.9 and 1.8 μM using a peptide and MLC as substrate, respectively) with ~100-fold greater selectivity over MLCK, MRCKb, and PKC. Hydroxyfasudil hydrochloride is reported to inhibit the Rock (Rho kinase)-mediated contraction in vitro.
Ito, K., et al. 2003. J. Physiol. 546, 823. Takemoto, M., et al. 2002. Circulation 106, 57. Shimokawa, H., et al. 1999. Cardiovasc. Res. 43, 1029.
Ver como otros han utilizado Hydroxyfasudil Hydrochloride (CAS 155558-32-0). Haga click en la entrada de PubMed .
PMID: # 35285797 Freitas, F.|Attwell, D.| et al. 2022. Elife. 11:
PMID: # 29344898 2018. Methods Mol. Biol. 1711: 351-398.
PMID: # 25172415 Kale, VP. et al. 2014. Cancer Lett. 354: 299-310.